Randomized, Crossover Safety and Pharmacokinetics Study of PT010

Trial Identifier: PT010003-00
Sponsor: Pearl Therapeutics, Inc.
NCTID:: NCT02197975
Start Date: August 2014
Primary Completion Date: October 2014
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United States, MD Baltimore, MD, United States, 21201